Photo: Maxim Bogodvid / RIA Novosti
Another Russian vaccine, developed by the research center “Vector” will be tested on people next month. This period was named CEO of the company Rinat Maksyutov.
“The expected launch of a study on volunteers from July 15,” he said.
Now completed preclinical testing. According to Maksudova, the drug may be registered in the fall. This will begin post-marketing clinical studies.
Video, photo All from Russia.